Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its peers.
The statistical interaction between genetic susceptibility and lifestyle was significant in the larger cohort and showed similar directional trends in the Indian cohort, according to the study.
Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.
Barclays 28th Annual Global Healthcare Conference March 10, 2026 3:00 PM EDTCompany ParticipantsEmily Leproust ...
In this GEN Learning Lab, our expert panelists Linda Orzolek, MS, MB, Xuhuai Ji, MD, PhD, and Christina Chang, PhD, will discuss the current landscape of imaging- and next-generation sequencing-based ...
Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.
The genomics industry is undergoing a profound transformation, moving decisively from a research-focused field to one centered on widespread clinical implementation. This shift sees high-throughput ...
An international research team has succeeded in developing a new version of RNA building blocks with higher chemical reactivity and photosensitivity. This can significantly reduce the production time ...
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. If your tools are held together by hope and muscle ...
Megan DeMatteo is an independent journalist and editor covering all things money, lifestyle and web3. She has written for notable publications including Marie Claire, CoinDesk, Insider and more. She ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results